An investigation into the cannabinoid receptor type 2 as a therapeutic target for childhood cerebral hypoxia
0 sources
An investigation into the cannabinoid receptor type 2 as a therapeutic target for childhood cerebral hypoxia
Summary
An investigation into the cannabinoid receptor type 2 as a therapeutic target for childhood cerebral hypoxia is a doctoral thesis[1].
Key Facts
- An investigation into the cannabinoid receptor type 2 as a therapeutic target for childhood cerebral hypoxia authored Jack Rivers-Auty[2].
- An investigation into the cannabinoid receptor type 2 as a therapeutic target for childhood cerebral hypoxia's instance of is recorded as doctoral thesis[3].
- An investigation into the cannabinoid receptor type 2 as a therapeutic target for childhood cerebral hypoxia's publisher is recorded as OUR Archive[4].
- An investigation into the cannabinoid receptor type 2 as a therapeutic target for childhood cerebral hypoxia's language of work or name is recorded as English[5].
- An investigation into the cannabinoid receptor type 2 as a therapeutic target for childhood cerebral hypoxia's country of origin is recorded as New Zealand[6].
- An investigation into the cannabinoid receptor type 2 as a therapeutic target for childhood cerebral hypoxia's publication date is recorded as +2013-00-00T00:00:00Z[7].
- An investigation into the cannabinoid receptor type 2 as a therapeutic target for childhood cerebral hypoxia's main subject is recorded as stroke[8].
- An investigation into the cannabinoid receptor type 2 as a therapeutic target for childhood cerebral hypoxia's main subject is recorded as inflammation[9].
- An investigation into the cannabinoid receptor type 2 as a therapeutic target for childhood cerebral hypoxia's main subject is recorded as brain damage[10].
- An investigation into the cannabinoid receptor type 2 as a therapeutic target for childhood cerebral hypoxia's main subject is recorded as neuroscience[11].
- An investigation into the cannabinoid receptor type 2 as a therapeutic target for childhood cerebral hypoxia's main subject is recorded as pharmacology[12].
- An investigation into the cannabinoid receptor type 2 as a therapeutic target for childhood cerebral hypoxia's main subject is recorded as animal model[13].
- An investigation into the cannabinoid receptor type 2 as a therapeutic target for childhood cerebral hypoxia's work available at URL is recorded as https://ourarchive.otago.ac.nz/handle/10523/4350[14].
- An investigation into the cannabinoid receptor type 2 as a therapeutic target for childhood cerebral hypoxia's Handle ID is recorded as 10523/4350[15].
- An investigation into the cannabinoid receptor type 2 as a therapeutic target for childhood cerebral hypoxia's title is recorded as An investigation into the cannabinoid receptor type 2 as a therapeutic target for childhood cerebral hypoxia[16].
- An investigation into the cannabinoid receptor type 2 as a therapeutic target for childhood cerebral hypoxia's copyright holder is recorded as Jack Rivers-Auty[17].
- An investigation into the cannabinoid receptor type 2 as a therapeutic target for childhood cerebral hypoxia's thesis submitted to is recorded as University of Otago[18].
- An investigation into the cannabinoid receptor type 2 as a therapeutic target for childhood cerebral hypoxia's on focus list of Wikimedia project is recorded as NZThesisProject[19].
- An investigation into the cannabinoid receptor type 2 as a therapeutic target for childhood cerebral hypoxia's copyright status is recorded as copyrighted[20].
- An investigation into the cannabinoid receptor type 2 as a therapeutic target for childhood cerebral hypoxia's thesis committee member is recorded as Stephen Bunn[21].
- An investigation into the cannabinoid receptor type 2 as a therapeutic target for childhood cerebral hypoxia's thesis committee member is recorded as Paul Smith[22].
- An investigation into the cannabinoid receptor type 2 as a therapeutic target for childhood cerebral hypoxia's thesis committee member is recorded as John C Ashton[23].
Body
Designation and Status
An investigation into the cannabinoid receptor type 2 as a therapeutic target for childhood cerebral hypoxia's instance of is recorded as doctoral thesis[3].